Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report
Year: 2026
Type: article
Study design: Case Report
Source: Immunotherapy
Authors: Zhiqiang Li, Yufei Li, Yuhan Zhang, Qiuxia Ye, Jing He, Mingwei Li
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204187118